Morgan Stanley’s Calidi Biotherapeutics CLDI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441 | Sell |
160
-8
| -5% | -$22 | ﹤0.01% | 7464 |
|
|
2025
Q1 | $1.14K | Sell |
168
-42
| -20% | -$286 | ﹤0.01% | 7265 |
|
|
2024
Q4 | $2.9K | Buy |
210
+42
| +25% | +$580 | ﹤0.01% | 7127 |
|
|
2024
Q3 | $2.3K | Buy |
168
+8
| +5% | +$110 | ﹤0.01% | 7101 |
|
|
2024
Q2 | $3.84K | Hold |
160
| – | – | ﹤0.01% | 6921 |
|
|
2024
Q1 | $10.8K | Sell |
160
-160
| -50% | -$10.8K | ﹤0.01% | 6674 |
|
|
2023
Q4 | $57.9K | Buy |
+320
| New | +$57.9K | ﹤0.01% | 6340 |
|